The 88305 Question: How an Old Pathology Valuation Suddenly Became a Live CMS Issue
A surprisingly consequential pathology issue is buried in the summer 2026 Medicare Physician Fee Schedule rulemaking. CMS has not yet proposed a new work RVU for CPT 88305, the ubiquitous Level IV surgical pathology code. Instead, following an outside nomination, CMS is asking whether the 88305 surgical pathology family is potentially misvalued and whether action should occur for 2027 or in future rulemaking.
That distinction is important. There is already a separate, roughly 4 percent proposed reduction in the 2027 global payment for 88305 arising from ordinary fee-schedule changes. The potentially much larger question is whether CMS will reopen the assumptions underlying the code’s physician work itself. CAP describes the misvalued-code inquiry here, while ASCP separately describes the proposed 2027 payment decrease. (College Of American Pathologists)
What makes the episode especially interesting is that 88305 is not simply an untouched relic of the original Harvard RBRVS studies, as an initial glance at its history might suggest. The AMA’s unusually deep online archive of RUC documents—thousands of pages of meeting minutes, recommendations, surveys, comparator discussions and historical review tables—makes it possible to reconstruct what actually happened. The resulting story is stranger, and more informative, than either “Harvard valued it decades ago” or “the RUC recently valued it.”
The AMA RUC Archive: An Extremely Nerdy Paper Trail
The AMA has retained an extraordinary documentary history of the Relative Value Scale Update Committee. Individual meeting files can run well over 100 pages, and the archive across many years runs to thousands of pages. The AMA’s RBRVS/RUC databases can identify when a code was last reviewed; the underlying meeting minutes then reveal what was surveyed, which reference services were used, what the specialty societies proposed, and what the RUC actually decided.
For 88305, the critical documents are the October 2009 RUC minutes and the April 2010 RUC minutes. For immunohistochemistry, the particularly revealing document is the April 2014 RUC meeting record. (American Medical Association)
Those records show that the present controversy is not about a code that escaped scrutiny. 88305 was scrutinized. Its 25-minute physician-time assumption was specifically re-surveyed and affirmed.
That makes the current challenge more significant.
Harvard Origins—and the 2009 Challenge
88305 was originally among the services whose physician work was derived from the Harvard studies used to create the Resource-Based Relative Value Scale.
By 2008–2009, CMS and the RUC were deliberately revisiting high-volume codes that still rested on Harvard-era valuations. The pathology tissue-examination family was caught in that exercise.
The College of American Pathologists and the American Academy of Dermatology argued that the old Harvard pathology work was unusually substantial. According to the RUC record, multiple vignettes had been used and 191 pathologists had participated. The societies argued that a contemporary RUC survey might not produce a dataset as large or as precise. (American Medical Association)
That position nearly carried the day. The RUC Research Subcommittee voted 5–4 in favor of the specialty societies’ proposed methodology, which would have continued to rely heavily on the Harvard work.
But the full RUC did something important: it declined simply to defer to Harvard. It concluded that a survey was needed to validate physician time and valuation and directed the family toward a standard RUC survey, an approved alternative methodology, or CPT restructuring. (American Medical Association)
Thus, the common shorthand that 88305 “still dates to Harvard” is only half true.
Its lineage does. Its later validation does not.
What Actually Happened in 2010
In April 2010, 88305 returned to the RUC with fresh survey data.
The result deserves close attention.
The RUC minutes state that the specialty society and RUC agreed that the surveyed physician time accurately reflected the service. The new survey produced 25 minutes of intraservice physician time for 88305. The RUC compared it with CPT 88323, which at that time carried 56 minutes of intraservice time and substantially greater work. (American Medical Association)
But the survey produced another remarkable number: the 25th-percentile surveyed work RVU was 1.50.
The existing 88305 work RVU was only 0.75.
The specialty society did not ask the RUC to double the work RVU to 1.50. Instead, it recommended leaving the existing value unchanged. The RUC agreed that there was no compelling evidence to alter the 0.75 value and reaffirmed it. (American Medical Association)
The 2010 result was therefore a peculiar hybrid:
The Harvard-derived 0.75 work RVU survived, but the 25-minute physician time was freshly surveyed and explicitly validated by the RUC.
This is an important correction to the simple “ancient Harvard value” story. Contemporary reporting later treated 88305’s professional component as having undergone a genuine 2010 revaluation; when CMS subsequently scrutinized the code again, CAP successfully argued that the physician work had just been reviewed, allowing the next major dispute to center on practice expense and the technical component. CAP TODAY’s detailed 2012 account describes that history and the subsequent 52 percent reduction in the 88305 technical component for 2013. (CAP Today)
That history makes the new controversy considerably sharper. CMS is not being asked to discard an untouched 35-year-old time estimate. It is being presented with empirical evidence challenging a 25-minute estimate that the RUC specifically re-surveyed and accepted in 2010.
Maryland: Turning the Fee Schedule’s Own Arithmetic Against It
The catalyst for the current CMS inquiry is the Maryland Health Care Commission, not CAP, AMA, or CMS itself.
MHCC used Maryland’s All-Payer Claims Database to examine whether assigned PFS physician times were plausible when compared with the number of services physicians actually billed during a day. Its analysis was described in a June 2026 Health Affairs Forefront article. (Health Affairs)
The method is almost disarmingly simple.
For a given physician-day, the number of billed services was multiplied by the intraservice physician time assigned to that CPT code. MHCC looked for days on which a single code by itself generated more than eight hours of nominal physician work, and then examined the other services billed by the same physician on those days.
88305 produced the most dramatic findings.
Using the PFS assumption of 25 minutes per 88305, MHCC identified 1,763 provider-days on which 88305 alone generated more than eight hours of assigned intraservice time. On 587 provider-days, 88305 alone generated more than 24 hours of physician time. When other billed services were incorporated, the average nominal PFS time on those extraordinary days reached about 37 hours. (Health Affairs)
MHCC also pointed to an earlier Urban Institute empirical study that reported a median observed intraservice time of only about two minutes for 88305, although that pilot was far smaller and methodologically much less definitive than the Maryland claims analysis. (LabReflex)
The Maryland exercise does not prove that 88305 “really takes two minutes,” nor does a 30-hour calculated workday establish improper billing. In fact, the analysis should not be interpreted as fraud detection. What it does is pose a different validity question:
If 25 minutes represents typical physician intraservice work, how can ordinary claims volume repeatedly generate workdays that are physically impossible?
That question is difficult to answer merely by citing another RUC survey.
CMS accepted the MHCC nomination into its Potentially Misvalued Code process and is now expressly asking whether the 88305 family should be acted upon for 2027 or in future rulemaking. CAP says it had already become aware of the Maryland submission, developed a framework in anticipation of CMS action, and intends to defend the valuation of these services. (College Of American Pathologists)
The Multiples Dilemma
The Maryland argument becomes even more intriguing when applied to another familiar area of pathology: immunohistochemistry.
The RUC’s own 2014 records provide unusually clear numbers. When the restructured IHC codes were surveyed, 206 pathologists responded for CPT 88342, the initial single-antibody stain. The RUC recommended 25 minutes of intraservice physician time and 0.70 work RVUs. (American Medical Association)
For CPT 88341, each additional single-antibody stain, the same 206-pathologist survey produced a recommended work RVU of 0.65.
More strikingly, the RUC recommended 25 minutes of intraservice time for every additional antibody as well. The minutes explicitly acknowledge that the add-on service carried the same physician time as the base 88342 service, although slightly less work. The RUC even compared 88341 with 88305 and observed that both carried 25 minutes of intraservice time. (American Medical Association)
This creates a striking multiplication problem.
A specimen reported with an initial 88342 and five additional 88341 services would, under the RUC time model, represent:
25 + 25 + 25 + 25 + 25 + 25 = 150 minutes
That is two and a half hours of pathologist intraservice time for a six-antibody panel.
The problem is not that IHC interpretation requires no physician work. Some stains can be difficult, heterogeneous or critical to resolving a challenging diagnosis.
Rather, the difficulty lies in assuming that physician work is linearly additive.
A six-stain panel is ordinarily interpreted as a case. The pathologist begins with the morphology and a differential diagnosis, examines the panel, and integrates the findings. One antibody may require prolonged scrutiny. Another may resolve the diagnosis. Several may simply be cleanly negative and recognizable almost immediately.
Six stains are not necessarily six independent 25-minute diagnostic encounters.
The RUC’s unit-by-unit valuation can therefore produce a completely plausible answer to the question, “How much work can be involved in interpreting this stain?” while producing a much less plausible answer to the question, “How many physician hours does this patient’s panel represent?”
That is the multiples dilemma.
And it is essentially the same dilemma that Maryland has now exposed for 88305 at the level of the entire workday.
How Could This Get Through the RUC?
The historical documents suggest an answer that is less accusatory—and more interesting—than simply saying the RUC got the numbers wrong.
The RUC system is built heavily around individual service vignettes, survey responses, reference codes and internal rank order.
A pathologist considering an IHC vignette may reasonably think about finding the appropriate area, examining the slide and controls, assessing localization and staining quality, considering artifacts, integrating the result with the H&E findings, revising a differential diagnosis, and producing a report. Twenty-five minutes may seem defensible when respondents are asked to conceptualize the entire physician work associated with an isolated service.
The RUC then asks whether that service is appropriately valued relative to established services.
The 2014 IHC record illustrates this perfectly. For 88342 and 88341, the RUC used 88305 itself as a reference service. Since 88305 was already accepted as a 25-minute service, another pathology service could be placed into appropriate relative order against it. (American Medical Association)
The structure can therefore become somewhat circular:
An established service helps validate a newer service; the newer service becomes an established comparator; subsequent services are then valued relative to the expanding network of accepted codes.
The system can remain internally coherent while the absolute time scale becomes increasingly difficult to reconcile with actual daily throughput.
Maryland’s innovation is not a more sophisticated vignette. It is almost the opposite. It steps outside the system and asks whether all those carefully derived minutes can coexist within a 24-hour day.
A Curious Silence in the Pathology Trade Press
The issue has not literally gone unreported. CAP has alerted members and is actively opposing potential reductions. ASCP published an August 10 article. A pathology billing organization has discussed the proposal, and the LabReflex podcast devoted an August 10 episode specifically to the Maryland analysis and 88305. LabReflex’s discussion is unusually explicit about the 25-minute problem. (ASCP)
Still, the broader trade-press response has been surprisingly muted considering the possible financial importance of 88305.
The contrast with 2012 is notable. When CMS cut the 88305 technical component by 52 percent, CAP TODAY ran a prominent and detailed feature explaining the history, economics and implications. The present issue potentially reaches the physician-work foundation of 88305 itself, yet it has so far generated relatively little comparable explanatory journalism. (CAP Today)
There are several plausible explanations.
The first is mundane: nothing has actually been revalued yet. CMS has asked for comment. Editors may reasonably hesitate to portray a potentially misvalued-code nomination as an imminent giant payment cut.
The second is that the story is exceptionally technical. Understanding it requires excavating obscure RUC records from 2009, 2010 and 2014, distinguishing physician time from work RVUs, separating professional from technical components, and understanding why a 25-minute number can be important without constituting a claim-level time requirement. A Google search does not readily produce that history. The AMA’s thousands of pages of old RUC records do.
There may also be a more delicate editorial problem. Explaining why the Maryland methodology might threaten 88305 inevitably requires displaying the arithmetic. And once that arithmetic is displayed, adjacent examples such as IHC become rather conspicuous.
A trade publication trying to mobilize opposition to an 88305 reduction could therefore face an unusual dilemma: calling greater attention to the issue may also call greater attention to historical RUC assumptions that are difficult to explain in ordinary workflow terms.
There is no evidence that this accounts for any particular publication’s editorial decisions. It is simply an unusual feature of the story. The obvious defense of 88305—“claims data cannot measure the complexity of pathology”—is valid but incomplete. The harder question is what evidence would establish that 25 minutes is still the correct typical time when actual throughput repeatedly appears incompatible with it.
Why This May Be Bigger Than 88305
For now, 88305 and related surgical pathology services are the immediate issue. There is no CMS proposal cutting the 88305 work RVU to a specified new number.
But the methodological precedent could matter more than the first code affected.
Traditional RUC valuation asks physicians to estimate work and then uses other established services to maintain relativity across the fee schedule.
The Maryland approach asks a different question:
Do those estimates survive contact with empirical utilization?
Those two methods need not always produce the same answer.
Indeed, 88305 is an unusually powerful test case because its history removes one easy defense. The 25-minute figure cannot simply be dismissed as a forgotten number inherited from Harvard in 1992. The RUC revisited the issue in 2009, required a survey, reviewed the new data in 2010, and explicitly agreed that the surveyed 25-minute time accurately represented the service. (American Medical Association)
Four years later, the RUC assigned that same 25-minute intraservice time not only to an initial IHC antibody under 88342 but also to each additional antibody under 88341. (American Medical Association)
Those records make the current issue considerably more interesting than an ordinary fight over Medicare reimbursement.
The central question is becoming whether a valuation system based on surveys and internal relativity also needs an external reality check based on observable physician throughput.
If CMS decides that the answer is yes, 88305 may be only the first conspicuous pathology example.
Bottom Line
The surprising fact about 88305 is not that nobody ever revisited its Harvard-era valuation.
They did.
In 2009, the full RUC refused simply to accept the old Harvard assumptions. In 2010, pathologists were surveyed, 25 minutes of physician intraservice time was explicitly accepted, and the existing 0.75 work RVU was deliberately retained—even though the survey’s 25th-percentile work estimate was twice as high at 1.50.
Maryland has now approached the problem from the opposite direction. Instead of asking physicians how long a typical 88305 should take, it has asked what happens when Medicare’s 25 minutes are multiplied by what physicians actually bill.
The answer sometimes exceeds 24 hours in a day.
And the AMA’s own extensive historical RUC archive reveals an additional reason this debate may not remain confined to 88305: in IHC, a six-antibody panel can carry 150 minutes of nominal intraservice pathologist time under the same valuation logic.
The real story, therefore, is not simply whether CMS cuts 88305.
It is whether empirical throughput is about to become a serious external test of the RUC’s internally constructed world of physician time.
